US Health Department faces leadership turnover and restructuring
美國衛生部面臨領導層更迭與重組
The U.S.
美國衛生與公眾服務部（HHS）已進入一個重大的轉型期。
Department of Health and Human Services (HHS) has entered a period of significant transition.
自2025年起，該機構便致力於一項規模龐大的重組工作，旨在精簡聯邦運作。
Since 2025, the agency has navigated a massive restructuring effort aimed at streamlining federal operations.
在「讓美國再度健康」(MAHA)的議程下，該部將員工總數由8萬2千人裁減至6萬2千人，並將原有的28個部門整併為15個。
Under the 'Make America Healthy Again' (MAHA) agenda, the department reduced its workforce from 82,000 to 62,000 employees and consolidated its 28 divisions into 15.
推動此項變革的主要動力是員工優化倡議，旨在每年減少18億美元的官僚成本。
A major driver for this change is the workforce optimization initiative, which seeks to cut bureaucratic costs by $1.8 billion annually.
包括CDC、NIH和FDA在內的重要組織領導層人員更替頻繁，許多職位目前由代理官員暫代。
Leadership at key organizations like the CDC, NIH, and FDA has seen high turnover, with many roles now filled by acting officials.
這些變動引發了對組織穩定性的擔憂，因為經驗豐富員工的流失可能會影響該機構應對全國性公共衛生緊急狀況的能力。
These shifts have sparked concerns regarding institutional stability, as the rapid loss of experienced staff may affect the agency's ability to manage national health emergencies.
此外，2026年的轉向將技術與數據職位歸入首席資訊長管轄之下，以實現運作集中化。
While the administration argues these measures improve efficiency, the public health community remains focused on how these changes will impact ongoing biomedical research, vaccine policies, and essential services for patients and healthcare providers across the country.
